Highnoon Laboratories Limited: Financial Results for the Quarter Ended
Summary
Highnoon Laboratories Limited reported a revenue of Rs 21.49 billion and a net profit of Rs 2.71 billion for the nine months ended September 30, 2026, showing moderate growth compared to the previous year.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | PKR 21.49 billion | PKR 20.30 billion | +5.8% |
| Net Profit | PKR 2.71 billion | PKR 2.68 billion | +1.3% |
| Earnings Per Share (EPS) | PKR 51.22 | PKR 50.59 | +1.3% |
| Gross Profit | PKR 12.35 billion | PKR 11.20 billion | +10.8% |
| Cash and Bank Balances | PKR 1.05 billion | PKR 0.58 billion | +81.3% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue increased to Rs 21.49 billion from Rs 20.30 billion, a growth of 5.85% year-over-year.
- Net profit slightly increased to Rs 2.71 billion from Rs 2.68 billion, reflecting a growth of 1.25%.
- Earnings per share improved to Rs 51.22 from Rs 50.59, indicating a positive trend in profitability.
Highnoon Laboratories Limited (HINOON) on Nafa
Last price Rs 960.87 · Pharmaceuticals · You can own HINOON shares from your phone.
More HINOON announcements
- NoticeTransmission of Quarterly Report for the Period Ended September 30, 2026
- NoticeBoard Meeting
- Insider tradeDirector Tehmina Saeed Chaudhury sold 10,000 shares at Rs 916.71Filed as: Insider Transaction
- NoticeTransmission of Quarterly Report for the Period Ended 30.06.2026
- NoticeBoard Meeting
- Material informationShariah Compliance Confirmed by Meezan BankHighnoon Laboratories receives Shariah Screening Compliance Confirmation from Meezan Bank, ensuring inclusion in PSX-KMI All Share Islamic Index.
Source: Highnoon Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.